CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $421,679
- in 7 filings, $422K under 10b5-1 plans
Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Lucera Erick Chief Financial Officer | Sale 10b5-1 | −1,991 | $16.82 | $33K | 117,775 |
| 2026-08-13 | Lucera Erick Chief Financial Officer | Sale 10b5-1 | −1,797 | $26.28 | $47K | 119,766 |
| 2026-06-25 | Lucera Erick Chief Financial Officer | Sale | −2,362 | $20.37 | $48K | 121,563 |
| 2026-05-13 | Lucera Erick Chief Financial Officer | Sale 10b5-1 | −1,448 | $18.36 | $27K | 123,925 |
| 2026-04-01 | Lucera Erick Chief Financial Officer | Sale 10b5-1 | −5,727 | $18.64 | $107K | 125,373 |
| 2026-02-12 | Lucera Erick Chief Financial Officer | Grant or award | +65,000 | 131,100 | ||
| 2026-02-12 | Lucera Erick Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2025-03-31 | Lucera Erick Chief Financial Officer | Grant or award | +66,100 | 66,100 | ||
| 2025-03-31 | Lucera Erick Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +214,500 | 214,500 |
Page 1 of 1 · 9 trades